Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-16, Stock:JNJ, The news for the past five days is as follows:
2018-03-09: NEWS1: FDA Approves Arm Indication for Medtronic’s Guardian Sensor 3.NEWS2: Medtronic Strengthens Diabetes Business with MiniMed Infusion Set.NEWS3: An Updated Technical Strategy on Johnson & Johnson.NEWS4: Is Big Pharma Using Corporate Tax Savings to Lower Drug Costs?.NEWS5: Is Big Pharma Using Corporate Tax Savings to Lower Drug Costs?.NEWS6: Pharma Stock Roundup: MRK Signs New Cancer Deal, DERM's Acne Candidate Fails.NEWS7: Pharma Stock Roundup: MRK Signs New Cancer Deal, DERM's Acne Candidate Fails.NEWS8: Stocks to Watch: Qualcomm, Netflix, Tesla, Chesapeake, Wynn, J&J, GM, Mattel, Big Lots, Finisar.NEWS9: Today’s Research Reports on Stocks to Watch: Johnson & Johnson and InVivo Therapeutics.NEWS10: [$$] Johnson & Johnson Says Discounts Cut the Prices for Its Drugs, Though Revenue Rose.
2018-03-12: NEWS1: Genomic Health Hits its Inflection Point.NEWS2: Genomic Health Hits its Inflection Point.NEWS3: Genomic Health Hits its Inflection Point.NEWS4: The 1 Big Risk That Every Drugmaker Fears.NEWS5: The 1 Big Risk That Every Drugmaker Fears.NEWS6: The 1 Big Risk That Every Drugmaker Fears.
2018-03-13: NEWS1: The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Johnson & Johnson Shareholders and a Lead Plaintiff Deadline of April 9, 2018.NEWS2: How Merck’s Diabetes Portfolio Performed in 2017.NEWS3: 3 Rules You Need for Picking Dividend Stocks.NEWS4: 3 Rules You Need for Picking Dividend Stocks.NEWS5: Noteworthy Tuesday Option Activity: PSA, EMN, JNJ.NEWS6: Noteworthy Tuesday Option Activity: PSA, EMN, JNJ.NEWS7: Why Geron Corporation Stock Is Rising Today.NEWS8: Why Geron Corporation Stock Is Rising Today.NEWS9: Lifshitz & Miller LLP Announces Investigation of 8point3 Energy Partners LP, Grandpoint Capital, Inc., Hardinge Inc., Johnson & Johnson, LJM Funds Management Ltd., Nationstar Mortgage Holdings Inc. and Patterson Companies, Inc..NEWS10: Why Geron Corporation Stock Is Rising Today.NEWS11: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 14, 2018.NEWS12: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 14, 2018.NEWS13: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS14: Johnson & Johnson To Participate In Barclays Healthcare Conference At 10:15 AM.NEWS15: Johnson & Johnson To Participate In Barclays Healthcare Conference At 10:15 AM.NEWS16: Johnson & Johnson To Participate In Cowen Healthcare Conference At 10:00 AM ET.NEWS17: Johnson & Johnson To Participate In Cowen Healthcare Conference At 10:00 AM ET.
2018-03-14: NEWS1: South Dakota sues opioid makers as litigation swells.NEWS2: Dow Stocks Drop As Boeing, Apple Weigh; Bitcoin Dives To 1-Mo. Low.NEWS3: To stay on cutting edge, major corporations like Johnson & Johnson seek innovation within, outside their walls.NEWS4: VIG, IGN: Big ETF Inflows.NEWS5: VIG, IGN: Big ETF Inflows.NEWS6: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS7: Forget Remicade -- Here's How Johnson & Johnson Plans to Grow.NEWS8: Forget Remicade -- Here's How Johnson & Johnson Plans to Grow.NEWS9: Forget Remicade -- Here&apos;s How Johnson & Johnson Plans to Grow.NEWS10: Doctors hunt for hidden cancers with glowing dyes.
2018-03-15: NEWS1: Why Google co-founder Sergey Brin was using a robot to put sutures in synthetic tissue.NEWS2: Why Google co-founder Sergey Brin was using a robot to put sutures in synthetic tissue.NEWS3: Here's Why Shorting Geron Corporation Stock Is a Terrible Idea.NEWS4: Here's Why Shorting Geron Corporation Stock Is a Terrible Idea.NEWS5: Here&apos;s Why Shorting Geron Corporation Stock Is a Terrible Idea.NEWS6: What Analysts Recommend for Novartis in March 2018.NEWS7: Understanding the Performance of Merck’s Hospital Acute Care Drugs Noxafil and Cubicin.NEWS8: Understanding Merck’s Immunology Segment Performance in 4Q17 and 2017.

Answer: Rise